Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants

• Status: NOT_YET_RECRUITING
• Trial end date: 2026-03-19

Summary

The purpose of the study if to evaluate the effect of Repotrectinib on the drug levels of transporter and CYP P450 probe substrates in healthy adult participants.

• Phase: PHASE1

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Bupropion; Digoxin; Flurbiprofen; Metformin; Omeprazole; repotrectinib; Rosuvastatin Calcium